ACON Aclarion, Inc.

2.350USD+2.62%Mkt Cap: 6.77M $P/E: —

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The c…

Key Statistics

Company
Market Cap6.77M USD
Enterprise Value-9.69M USD
Revenue (TTM)83.77K USD
Gross Profit6.83K USD
Net Income (TTM)-7.23M USD
Revenue/Share0.06 USD
Last Price2.350 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.42
PEG—
EV/EBITDA1.02
EV/Revenue-115.73
P/S78.80
P/B0.33
EPS (TTM)-7.16
EPS (Forward)-5.47
52W Range
1.9504% of range12.03
52W High12.03 USD
52W Low1.950 USD
Profitability
Gross Margin9.02%
Oper. Margin-11503.18%
EBITDA Margin0.00%
Profit Margin-9551.87%
ROE-56.36%
ROA-52.91%
Growth
Revenue Growth30.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.16M USD
CapEx (TTM)203.90K USD
FCF Margin-6354.42%
FCF Yield-78.59%
Net Debt-16.30M USD
Net Debt/EBITDA1.72
Balance Sheet
Debt/Equity—
Current Ratio16.20
Quick Ratio15.74
Book Value/Sh6.91 USD
Cash/Share5.65 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMar 28, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.625 USD
Upside (mean)+224.5%
Target Range7.500 USD – 7.750 USD
7.500+224.5% to mean7.750
# Analysts2
Ownership
Shares Out.2.88M
Float2.52M
Insiders23.98%
Institutions4.00%
Short Interest
Short Ratio1.2d
Short % Float2.64%
Short % Out.2.64%
Shares Short76.01K
Short (prev mo.)61.99K
Technical
SMA 502.447 (-4.0%)
SMA 2003.175 (-26.0%)
Beta1.21
S&P 52W Chg16.45%
Avg Vol (30d)55.34K
Avg Vol (10d)66.26K
Technical Indicators
RSI (14)44.5
MACD-0.0438
MACD Signal-0.0174
MACD Hist.-0.0264
BB Upper2.796 USD
BB Middle2.500 USD
BB Lower2.204 USD
BB Width23.68%
ATR (14)0.1607 USD
Vol Ratio (20d)0.22x